Greene Barry E 4
4 · Sage Therapeutics, Inc. · Filed Nov 15, 2022
Insider Transaction Report
Form 4
Greene Barry E
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2022-11-10$34.48/sh+14,500$500,022→ 46,940 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $34.19 USD to $34.86 USD. The price reported above reflects the weighted average purchase price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.